
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/">
  <dc:type>info:eu-repo/semantics/bachelorThesis</dc:type>
  <dc:rights>http://creativecommons.org/licenses/by-nc-nd/2.0/at/legalcode</dc:rights>
  <dc:contributor>Mrdović, Igor B., 1959-</dc:contributor>
  <dc:contributor>Ostojić, Miodrag, 1946-</dc:contributor>
  <dc:contributor>Babić, Rade, 1955-</dc:contributor>
  <dc:contributor>Matić, Mihajlo, 1949-</dc:contributor>
  <dc:subject xml:lang="srp">OSNO - Opšta sistematizacija naučnih oblasti, Kardiologija</dc:subject>
  <dc:subject xml:lang="eng">OSNO - Opšta sistematizacija naučnih oblasti, Kardiologija</dc:subject>
  <dc:subject xml:lang="srp">krvarenje, PCI, testovi funkcije trombocita</dc:subject>
  <dc:subject xml:lang="eng">PCI, bleeding, platelet function testing</dc:subject>
  <dc:subject xml:lang="srp">616.12:616.155.2(043.3) </dc:subject>
  <dc:date>2016</dc:date>
  <dc:language>srp</dc:language>
  <dc:identifier>https://phaidrabg.bg.ac.rs/o:13233</dc:identifier>
  <dc:identifier>cobiss:48243471</dc:identifier>
  <dc:identifier>thesis:3933</dc:identifier>
  <dc:format>142 lista</dc:format>
  <dc:format>2834243 bytes</dc:format>
  <dc:description xml:lang="srp">Uvod: Krvarenje nakon perkutanih koronarnih intervencija (PCI) je važna komplikacija sa
značajnim nepovoljnim uticajem na prognozu. Cilj: Da se proceni prediktivna vrednost preterano
niske rezidualne reaktivnosti trombocita na dvojnu antiagregacionu terapiju aspirinom i
klopidogrelom, za krvarenje nakon elektivne PCI. Metodologija i rezultati: Kod 481-nog
uzastopnog bolesnika sa elektivnom PCI, izvršeno je testiranje funkcije trombocita pomoću
Multiplejt analizatora, gde je ispitivana reaktivnost trombocita indukovana arahidonskom
kiselinom (ASPI) i adenozin difosfatom (ADP), neposredno pre PCI i 24 časa nakon PCI.
Pacijenti su praćeni prosečno 15.34±7.19 meseci. Primarni cilj studije bio je pojava svakog
krvarenja, dok je sekundarni cilj bila pojava ishemijskog neželjenog srčanog događaja (MACE).
Učestalost svih, BARK≤2, i BARK≥3 krvarenja prema BARK klasifikaciji je bila 19%, 18% i
1%, odgovarajuće. Grupe sa svim, i BARK≤2 krvarenjima, su imale niže prosečne vrednosti
multiplejtADP testa nakon 24 časa, u poređenju sa grupom bez krvarenja: 45.30±18.63 U prema
50.99±19.01 U; p=0.005; i 45.75±18.96 U prema 50.99 ± 18.99 U; p=0.01; odgovarajuće. Ženski
pol (HR 2.11; CI 1.37-3.25; p=0.001), prethodni infarkt miokarda (HR 0.56; CI 0.37-0.85;
p=0.006), niska telesna težina (HR 0.78; CI 0.62-0.98; p=0.03), i vrednosti multiplejt ADP testa
nakon 24 časa od PCI ispod medijane (HR 0.75; CI 0.61-0.93; p=0.009) su bili nezavisni
prediktori svih krvarenja, određeni pomoću Koksove univarijantne analize. Nakon uravnoteženja
razlika između poređenih grupa, multiplejt ADP test nakon 24h, je bio jedini nezavisni prediktor
za sva (HR 0.7; CI 0.56-0.87; p=0.002), i BARK≤2 (HR 0.71; CI 0.56-0.89; p=0.003) krvarenja
putem Koksove univarijantne analize. Zaključak: MultiplejtADP test pre i nakon PCI, je bio
povezan sa svim i BARK≤2 krvarenjima nakon elektivne PCI...</dc:description>
  <dc:description xml:lang="eng">Background: Bleeding after percutaneous coronary interventions (PCI) is an important
complication with impact on prognosis. Aim: To evaluate the predictive value of enhanced
platelet responsiveness to dual antiplatelet therapy with aspirin and clopidogrel, for bleeding,
after elective PCI. Method and results: We performed multiple electrode aggregometry (MAE)
platelet functional tests induced by arachidonic acid (ASPI) and adenosine-diphosphate (ADP)
before PCI, and 24 hours after PCI, in 481 elective PCI patients who were followed-up for an
average of 15.34±7.19 months. Primary end point was the occurrence of any bleeding, while
ischemic major adverse cardiovascular event (MACE) was a secondary endpoint. The incidence
of total, BARC≤2, and BARC≥3 bleeding, according to BARC classification, was 19%, 18% and
1%, respectively. Groups with any, and BARC≤2 bleeding, had a lower average value of MAE
ADP test after 24h, compared to the group without bleeding: 45.30±18.63 U vs. 50.99±19.01 U;
p=0.005; and 45.75±18.96 U vs. 50.99 ± 18.99 U; p=0.01; respectively. Female gender (HR
2.11; CI 1.37-3.25; p=0.001), previous myocardial infarction (HR 0.56; CI 0.37-0.85; p=0.006),
lower body mass (HR 0.78; CI 0.62-0.98; p=0.03), and MAE ADP test after 24h (HR 0.75; CI
0.61-0.93; p=0.009) were the independent predictors for any bleeding by Cox univariate analysis.
After adjustment, MAE ADP test after 24h, was the only independent predictor for any (HR 0.7;
CI 0.56-0.87; p=0.002), and BARC≤2 (HR 0.71; CI 0.56-0.89; p=0.003) bleeding, by Cox
multivariate analysis. Conclusion:MAE ADP test before and after PCI, was associated with any,
and BARC≤2 bleeding after elective PCI.
</dc:description>
  <dc:description xml:lang="srp">kardiovaskularna medicina - interventna kardiologija / Cardiovascular medicine- Interventional cardiology  
Datum odbrane: 31.08.2016. </dc:description>
  <dc:title xml:lang="srp">Uticaj stepena inhibicije funkcije trombocita nakon primene dvojne antiagregacione terapije na ishod bolesnika lečenih elektivnom perkutanom koronarnom intervencijom : doktorska disertacija</dc:title>
  <dc:creator>Čolić, Mirko D., 1961-</dc:creator>
</oai_dc:dc>
